Page History

This dataset includes brain MRI scans of adult brain glioma patients, comprising of 4 structural modalities (i.e., T1, T1c, T2, T2-FLAIR) and associated manually generated ground truth labels for each tumor sub-region (enhancement, necrosis, edema), as well as their MGMT promoter methylation status. These scans are a collection of data from existing TCIA collections, but also cases provided by individual institutions and willing to share with a cc-by license.

The BraTS dataset describes a retrospective collection of brain tumor structural mpMRI scans of 2,040 patients (1,480 here), acquired from multiple different institutions under standard clinical conditions, but with different equipment and imaging protocols, resulting in a vastly heterogeneous image quality reflecting diverse clinical practice across different institutions. The 4 structural mpMRI scans included in the BraTS challenge describe a) native (T1) and b) post-contrast T1-weighted (T1Gd (Gadolinium)), c) T2-weighted (T2), and d) T2 Fluid Attenuated Inversion Recovery (T2-FLAIR) volumes, acquired with different protocols and various scanners from multiple institutions. Furthermore, data on the O[6]-methylguanine-DNA methyltransferase (MGMT) promoter methylation status is provided as a binary label. Notably, MGMT is a DNA repair enzyme that the methylation of its promoter in newly diagnosed glioblastoma has been identified as a favorable prognostic factor and a predictor of chemotherapy response.

It is curated for computational image analysis of segmentation and prediction of the MGMT promoter methylation status.